CytomX Therapeutics, Inc. SEC filings CTMX

CytomX Therapeutics, Inc. has 800 filings in SEC EDGAR's recent list, going back to Sep 28, 2010. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

CytomX Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 28, 2026 —
4/A Form 4/a Oct 16, 2026 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
S-8 Employee stock plan registration Aug 6, 2026 —
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 3, 2026 —
4 Insider transaction Jul 30, 2026 Jul 24, 2026
3 Initial insider ownership Jul 30, 2026 Jul 24, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
8-K Current report
Officer or director change
Jul 27, 2026 Jul 24, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
8-K Current report
Material agreement
Jun 3, 2026 May 29, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 17, 2026
PRE 14A Preliminary proxy statement Apr 20, 2026 Jun 17, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 16, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
8-K Current report
Other events
Mar 19, 2026 Mar 17, 2026
424B5 Prospectus supplement Mar 18, 2026 —
424B5 Prospectus supplement Mar 16, 2026 —
S-3ASR Automatic shelf registration Mar 16, 2026 —
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 4, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
144 Notice of proposed sale Nov 6, 2025 —
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 29, 2025 Oct 20, 2025
3 Initial insider ownership Oct 29, 2025 Oct 20, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 21, 2025 —
EFFECT Filing Aug 18, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
CORRESP Letter to the SEC Aug 14, 2025 —
UPLOAD Letter from the SEC Aug 13, 2025 —
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
S-3 Shelf registration Aug 7, 2025 —
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 9, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 9, 2025 —
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 11, 2025
8-K Current report
Other events
May 28, 2025 May 27, 2025
SCHEDULE 13G Ownership over 5% (passive) May 20, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 20, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
8-K Current report
Other events
May 13, 2025 May 12, 2025
424B5 Prospectus supplement May 12, 2025 —
8-K Current report
Results of operations, Other events
May 12, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 11, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
S-8 Employee stock plan registration Mar 6, 2025 —
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Listing notice
Feb 26, 2025 Feb 24, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4/A Filing Feb 10, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
4 Insider transaction Feb 6, 2025 Feb 4, 2025
8-K Current report
Officer or director change
Feb 3, 2025 Jan 30, 2025
8-K Current report
Exit or restructuring costs
Jan 6, 2025 Jan 6, 2025
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
4 Insider transaction Aug 22, 2024 Aug 20, 2024
EFFECT Filing Aug 19, 2024 —
CORRESP Letter to the SEC Aug 15, 2024 —
UPLOAD Letter from the SEC Aug 15, 2024 —
S-3 Shelf registration Aug 9, 2024 —
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Jun 17, 2024 Jun 12, 2024
4 Insider transaction Jun 14, 2024 Jun 12, 2024
SC 13G Ownership over 5% (passive) May 22, 2024 —
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
4 Insider transaction May 17, 2024 May 15, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 17, 2024 May 15, 2024
SC 13G Ownership over 5% (passive) May 13, 2024 —
8-K Current report
Other events
May 8, 2024 May 8, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
DEFA14A Additional proxy material May 1, 2024 —
DEFA14A Additional proxy material Apr 4, 2024 —
DEF 14A Proxy statement Apr 4, 2024 May 15, 2024
4 Insider transaction Mar 28, 2024 Mar 26, 2024
PRE 14A Preliminary proxy statement Mar 25, 2024 May 15, 2024
4 Insider transaction Mar 22, 2024 Mar 20, 2024
3 Initial insider ownership Mar 22, 2024 Mar 20, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 22, 2024 Mar 20, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
4 Insider transaction Mar 21, 2024 Mar 19, 2024
S-8 Employee stock plan registration Mar 11, 2024 —
8-K Current report
Results of operations
Mar 11, 2024 Mar 11, 2024
10-K Annual report Mar 11, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Dec 22, 2023 Dec 20, 2023
4 Insider transaction Dec 22, 2023 Dec 20, 2023
4 Insider transaction Dec 22, 2023 Dec 20, 2023
4 Insider transaction Dec 22, 2023 Dec 20, 2023
4 Insider transaction Dec 22, 2023 Dec 20, 2023
4 Insider transaction Dec 19, 2023 Dec 17, 2023
4 Insider transaction Dec 19, 2023 Dec 17, 2023
4 Insider transaction Dec 19, 2023 Dec 17, 2023
4 Insider transaction Dec 19, 2023 Dec 17, 2023
4 Insider transaction Dec 19, 2023 Dec 17, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
4 Insider transaction Sep 22, 2023 Sep 20, 2023
4 Insider transaction Sep 22, 2023 Sep 20, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CTMX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer
SEC CIK
1501989

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.